New MedTech for Erectile Dysfunction in Men with Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis Developed by Fine Treatment

OXFORD, UK / ACCESSWIRE / October 13, 2023 / Benign prostate enlargement, known as BPH or BPE, and chronic prostatitis are often accompanied by erectile dysfunction. It was confirmed that novel Thermobalancing therapy with Dr Allen’s Device reduces the size of enlarged prostate and helps to recover from chronic prostatitis. Now, a new clinical trial studying “The effect of Dr Allen’s Device and Thermobalancing Therapy on erectile dysfunction in men with chronic prostate diseases” registered at the World Health Organization via the ISRCTN Registry has been successfully completed.

Erectile dysfunction (ED) may occur in any man regardless of his age and race. However, ED is much more likely to develop after the age of 50. Almost half (48%) of all men in the UK say they experience difficulty getting or keeping an erection, while the overall prevalence of ED in North America is between 22-58% and the prevalence of ED is higher in Asian men compared to European men. Chronic prostatitis can cause erectile dysfunction due to inflammatory agents that are released during inflammation.

ED can also occur as a nasty side effect associated with the long-term use of medications for BPH and chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS).

Effective and safe at-home treatment with Dr Allen’s Device

The patented Thermobalancing therapy with Dr Allen’s Device is a novel out-of-hospital treatment designed for an easy at-home use. Dr Allen’s Device is registered with the British Medical Healthcare Agency, has been well tested in 5 clinical trials and during over 12 years on the market. A medical journal article sheds light on the science behind this medtech innovation: Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively.

The analysis of new clinical trial data on erectile dysfunction in men with BPH or CP/CPPS shows that the novel medical technology with Dr Allen’s Device improves ED safely, without any adverse impacts, and supports overall men’s health.

What men with BPH or CP/CPPS can experience after common standard treatments

  • Long-term courses of antibiotics are prescribed to men with CP/CPPS, even when bacteria have not been confirmed, and they are sometimes given to men with BPH. Such treatment suppresses the immune system and weakens the body, and may also cause allergies and other reactions.
  • Prostate massage cannot help but can cause damage to the delicate prostate tissue, bleeding around the prostate gland, development of prostatic calculi, acute epididymitis, and other health problems.
  • Anti-inflammatory drugs, such as, diclofenac; fenoprofen; ibuprofen; indomethacin; naproxen, and others can cause stomach ulcers, heart and kidney problems.
  • Alpha blockers, such as alfuzosin, doxazosin, terazosin, tamsulosin, and prazosin, can, in the long-term, reduce the quality of life in men by causing impotence, depression, testicular swelling and pain.
  • Hormonal drugs, such as 5 alpha reductase inhibitors: finasteride, Avodart, can be responsible for irreversible side effects: impotence, depression, testicle pain, and even diabetes.
  • Antidepressant drugs may lead to constipation, which aggravates the chronic process in the affected prostate gland.
  • Prostate surgeries remove or destroy prostate tissue. All surgical interventions are associated with complications. As a result, approximately 25% of patients suffer from depression after even a minimally invasive prostate surgery.

It is precisely these multiple side effects of common standard treatments what motivated Dr Simon Allen, an experienced doctor specialising in internal medicine, to design safe Thermobalancing therapy addressing unmet patient needs. Fine Treatment makes wearable Dr Allen’s Devices accessible around the world.

About Fine Treatment

Fine Treatment is a leading Oxford-based research and development company with a patented medical technology, called Thermobalancing therapy and Dr Allen’s Devices. Totally risk-free, this non-invasive treatment is proven to be highly effective. Designed to be worn on the body, the therapeutic Dr Allen’s Devices provide a unique, life-changing treatment for various health conditions, including prostate enlargement (BPH or BPE); chronic prostatitis; kidney stone disease; chronic low back pain; upper spine stiffness; knee pain and osteoarthritis; chronic headaches; and coronary heart disease.

Contact Information:

Alex Day
Customer Services Manager, Fine Treatment
Oxford, United Kingdom
Tel: +447958878300
Email: info@finetreatment.com

SOURCE: Fine Treatment

View source version on accesswire.com:
https://www.accesswire.com/792039/new-medtech-for-erectile-dysfunction-in-men-with-benign-prostatic-hyperplasia-bph-and-chronic-prostatitis-developed-by-fine-treatment

Staff

Recent Posts

CRISP Shared Services Announced as Implementation Center Awardee Under $255M National Public Health Data Modernization Program

The multi-year, CDC-funded program partners public health agencies with CRISP Shared Services to provide industry-leading…

1 hour ago

Promising Data on Transdermal Obesity Formulations Announced by Skinvisible

Results Demonstrate Significant Transdermal Performance of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Using Invisicare…

1 hour ago

Netsmart TheraOffice® Achieves ONC Certification for Enhanced Physical Therapy EHR and Practice Management

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Interoperability--Netsmart, a leading provider of healthcare technology solutions and services for community-based…

4 hours ago

Netsmart TheraOffice® Achieves ONC Certification for Enhanced Physical Therapy EHR and Practice Management

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Interoperability--Netsmart, a leading provider of healthcare technology solutions and services for community-based…

4 hours ago

Innovaccer Joins athenahealth’s Marketplace Program to Bring AI-Powered Provider Copilot to EHR

Innovaccer integrates its Provider Copilot with athenahealth EHR to automate clinical documentation, generate potential diagnoses,…

4 hours ago